Uptake of botulinum neurotoxin into cultured neurons

被引:132
作者
Keller, JE [1 ]
Cai, F
Neale, EA
机构
[1] US FDA, Ctr Biol Evaluat & Res, Lab Bacterial Toxins, Bethesda, MD 20892 USA
[2] NICHHD, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1021/bi0356698
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Botulinum neurotoxins (BoNTs) act within the synaptic terminal to block neurotransmitter release. The toxin enters the neuron by binding to neuronal membrane receptor(s), being taken up into an endosome-like compartment, and penetrating the endosome membrane via a pH-dependent translocation process. Once within the synaptic cytoplasm, BoNT serotypes A and E cleave separate sites on the C-terminus of the neuronal protein SNAP-25, one of the SNARE proteins required for synaptic vesicle fusion. In this study, we measured the effect of brief toxin exposure on SNAP-25 proteolysis in neuronal cell cultures as an indicator of toxin translocation. The results indicate that (1) uptake of both BoNT-A and -E is enhanced with synaptic activity induced by K+ depolarization in the presence of Ca2+ and (2) translocation of BoNT-A from the acidic endosomal compartment is slow relative to that of BoNT-E. Polyclonal antisera against each toxin protect cells when applied with the toxin during stimulation but has no effect when added immediately after toxin exposure, indicating that toxin endocytosis occurs with synaptic activity. Both serotypes cleave SNAP-25 at concentrations between 50 pM and 4 nM. IC50 values for SNAP-25 cleavage are approximately 0.5 nM for both serotypes. Inhibition of the pH-dependent translocation process by pretreating cultures with concanamycin A (Con A) prevents cleavage of SNAP-25 with IC50 values of similar to25 nM. Addition of Con A at times up to 15 min after toxin exposure abrogated BoNT-A action; however, addition of Con A after 40 min was no longer protective. In contrast, Con A inhibited, but did not prevent, translocation of BoNT-E even when added immediately after toxin exposure, indicating that pH-dependent translocation of BoNT-E is rapid relative to that of BoNT-A. This study demonstrates that uptake of both BoNT-A and -E is enhanced with synaptic activity and that translocation of the toxin catalytic moiety into the cytosol occurs at different rates for these two serotypes.
引用
收藏
页码:526 / 532
页数:7
相关论文
共 50 条
[1]   Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle [J].
Adler, M ;
Keller, JE ;
Sheridan, RE ;
Deshpande, SS .
TOXICON, 2001, 39 (2-3) :233-243
[2]   BOTULINUM-A NEUROTOXIN INHIBITS NONCHOLINERGIC SYNAPTIC TRANSMISSION IN MOUSE SPINAL-CORD NEURONS IN CULTURE [J].
BIGALKE, H ;
DREYER, F ;
BERGEY, G .
BRAIN RESEARCH, 1985, 360 (1-2) :318-324
[3]  
BINZ T, 1994, J BIOL CHEM, V269, P1617
[4]   BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25 [J].
BLASI, J ;
CHAPMAN, ER ;
LINK, E ;
BINZ, T ;
YAMASAKI, S ;
DECAMILLI, P ;
SUDHOF, TC ;
NIEMANN, H ;
JAHN, R .
NATURE, 1993, 365 (6442) :160-163
[5]   BINDING OF BOTULINUM NEUROTOXIN TO PURE CHOLINERGIC NERVE-TERMINALS ISOLATED FROM THE ELECTRIC ORGAN OF TORPEDO [J].
BLASI, J ;
EGEA, G ;
CASTIELLA, MJ ;
ARRIBAS, M ;
SOLSONA, C ;
RICHARDSON, PJ ;
MARSAL, J .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1992, 90 (02) :87-102
[6]   THE N-TERMINAL HALF OF THE HEAVY-CHAIN OF BOTULINUM TYPE A NEUROTOXIN FORMS CHANNELS IN PLANAR PHOSPHOLIPID-BILAYERS [J].
BLAUSTEIN, RO ;
GERMANN, WJ ;
FINKELSTEIN, A ;
DASGUPTA, BR .
FEBS LETTERS, 1987, 226 (01) :115-120
[7]   AN INTRACELLULAR STUDY OF THE ACTION OF REPETITIVE NERVE VOLLEYS AND OF BOTULINUM TOXIN ON MINIATURE END-PLATE POTENTIALS [J].
BROOKS, VB .
JOURNAL OF PHYSIOLOGY-LONDON, 1956, 134 (02) :264-277
[8]   THE ACTION OF BOTULINUM TOXIN ON MOTOR-NERVE FILAMENTS [J].
BROOKS, VB .
JOURNAL OF PHYSIOLOGY-LONDON, 1954, 123 (03) :501-515
[9]   THE ACTION OF BOTULINUM TOXIN ON THE NEURO-MUSCULAR JUNCTION [J].
BURGEN, ASV ;
DICKENS, F ;
ZATMAN, LJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1949, 109 (1-2) :10-24
[10]  
Coffield JA, 1997, J PHARMACOL EXP THER, V280, P1489